Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver
Bi-Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven L. Swendeman, Bongnam Jung, Deebly Chavez, Zhongwei Cao, Christina Christoffersen, Lars Bo Nielsen, Susan R. Schwab, Shahin Rafii, Timothy Hla
Bi-Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven L. Swendeman, Bongnam Jung, Deebly Chavez, Zhongwei Cao, Christina Christoffersen, Lars Bo Nielsen, Susan R. Schwab, Shahin Rafii, Timothy Hla
View: Text | PDF
Research Article Therapeutics Vascular biology

HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver

  • Text
  • PDF
Abstract

Regeneration of hepatic sinusoidal vasculature is essential for non-fibrotic liver regrowth and restoration of its metabolic capacity. However, little is known about how this specialized vascular niche is regenerated. Here we show that activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) by its natural ligand bound to HDL (HDL-S1P) induces liver regeneration and curtails fibrosis. In mice lacking HDL-S1P, liver regeneration after partial hepatectomy was impeded and associated with aberrant vascular remodeling, thrombosis and peri-sinusoidal fibrosis. Notably, this “maladaptive repair” phenotype was recapitulated in mice that lack S1P1 in the endothelium. Reciprocally, enhanced plasma levels of HDL-S1P or administration of SEW2871, a pharmacological agonist specific for S1P1 enhanced regeneration of metabolically functional vasculature and alleviated fibrosis in mouse chronic injury and cholestasis models. This study shows that natural and pharmacological ligands modulate endothelial S1P1 to stimulate liver regeneration and inhibit fibrosis, suggesting that activation of this pathway may be a novel therapeutic strategy for liver fibrosis.

Authors

Bi-Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven L. Swendeman, Bongnam Jung, Deebly Chavez, Zhongwei Cao, Christina Christoffersen, Lars Bo Nielsen, Susan R. Schwab, Shahin Rafii, Timothy Hla

×

Figure 7

Liver regeneration is suppressed in mice with inducible endothelial cell-specific deletion of S1pr1 (S1pr1iΔEC/iΔEC).

Options: View larger image (or click on image) Download as PowerPoint
Liver regeneration is suppressed in mice with inducible endothelial cell...
(A) Generation of inducible EC-specific deletion of S1pr1 in adult mice. Floxed S1pr1 (S1pr1f/f ) mice were bred with Cdh5-CreERT2 mice carrying tamoxifen response-Cre driven by EC-specific Cdh5/VE-cadherin promoter. Treatment of resultant mouse offspring with 200 mg/kg tamoxifen led to selective deletion of S1pr1 in ECs (S1pr1iΔEC/iΔEC). S1pr1f/f mice without Cre were similarly treated with tamoxifen and used as control group. Histology of the liver from control and S1pr1iΔEC/iΔEC mice that received sham operation is presented in Supplemental Figure 3A. (B–D) Recovery of liver mass (B), body weight (C) and survival rate (D) of hepatectomized control and S1pr1iΔEC/iΔEC mice. N= 7-8 animals per group. Statistical difference was determined by One way ANOVA throughout Figure 7. (E–G) Levels of plasma bilirubin and serum AST and ALT in S1pr1iΔEC/iΔEC and control mice after PH. N= 7-9 animals per group. (H–J) Sinusoidal vascular perfusion in S1pr1iΔEC/iΔEC and control mice after PH. Perfused vasculature was identified by examining distribution of i.v. injected B4-isolectin and VEGFR3 staining in the liver. Representative image and quantification of VEGFR3+isolectin+ LSECs area are shown in (I) and (J), respectively. Scale bar = 50 μm. N= 6-7 animals per group. (K) Rho pathway was activated in LSEC of S1pr1iΔEC/iΔEC mice after PH, as evidenced by increased level of p-MLC in VE-cadherin+ LSEC. Scale bar = 50 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts